• KameraOne

    Grieving families looking for answers after report alleges doctor denied life-saving transplants

    Grieving families spoke at a press conference on April 24 of their search for answers after the New York Times published an article on April 18, alleging Dr. J. Steve Bynon Jr. of Memorial Hermann-Texas Medical Center of manipulating records to ensure select patients became ineligible for receiving transplants.

  • Reuters

    UPDATE 1-UK-listed drugmaker Indivior seeks shareholder nod for US listing

    UK-listed drugmaker Indivior plans to seek shareholder approval next month for a primary listing in the United States, the company said on Thursday, which would add it to a growing list of firms leaving the London stock market. Indivior had, in February, announced its intent to shift its listing by the middle of the year to the U.S., which, it argued, reflected its growth opportunities as its proprietary treatments are U.S.-centred and U.S.-based investors account for nearly 50% of its overall shareholder base. The list of UK-based companies that have already listed in the United States includes ARM, the UK's biggest chip company, as well as building supplies firm CRH and plumbing equipment company Ferguson.

  • Evening Standard

    Scotland's powersharing deal collapses in bust-up between Greens and SNP

    The Bute House Agreement brought the Green Party into government for the first time anywhere in the UK